Evidence map›Paper›PMID 20973119›Full record

ArticleChemMedChem2011

Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.

William C Floyd, Gopal K Datta, Shinichi Imamura, Heidi M Kieler-Ferguson, Katherine Jerger, Andrew W Patterson, Megan E Fox, Francis C Szoka, Jean M J Fréchet, Jonathan A Ellman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemMedChem, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

William C FloydUniversity of California, Berkeley, 94720-1460, USA.
Gopal K Datta
Shinichi Imamura
Heidi M Kieler-Ferguson
Katherine Jerger
Andrew W Patterson
Megan E Fox
Francis C Szoka
Jean M J Fréchet
Jonathan A Ellman

Funding

Substrate Activity Screening: A New Approach to Inhibitor DiscoveryR01GM054051 · NIGMS · YALE UNIVERSITY · PI ELLMAN, JONATHAN A · 1997 to 2016
$5.2M
Biocompatible Dendritic Polymers : In Vivo ApplicationsR01EB002047 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SZOKA, FRANCIS C. · 2003 to 2009
$3.0M
Nanoscale delivery vehicles for antigen-based vaccinesR01EB005824 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI FRECHET, JEAN M · 2005 to 2008
$2.0M
NIBIB NIH HHS R01 EB 002047NIBIB NIH HHS R01 EB002047NIBIB NIH HHS R01 EB005824NIBIB NIH HHS R01-EB005824NIGMS NIH HHS R01 GM054051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsDendrimersDrug CarriersOligopeptidesAnimalsColonic NeoplasmsColorectal NeoplasmsDisease Models, AnimalDrug Evaluation, PreclinicalEndosomesFemaleMiceMice, Inbred BALB CSolubilityAntineoplastic AgentsDendrimersDrug CarriersOligopeptidestubulysin D

Identifiers

PMID20973119
PMCPMC3470805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.